Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02467231 · ClinicalTrials.gov registry record
Ovarian Reserve After Cancer: Longitudinal Effects
A clinical trial of Premature Ovarian Failure and Effects of Chemotherapy, sponsored by University of Pennsylvania.
- Active
- Registry status
- 196
- Enrollment target
- 1
- Study location
NCT02467231: Active study of Premature Ovarian Failure and Effects of Chemotherapy, sponsored by University of Pennsylvania.
NCT02467231 is a study of Premature Ovarian Failure and Effects of Chemotherapy that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 196 participants, above the 25-participant average among 3 other Premature Ovarian Failure trials with a reported enrollment target (684% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02467231, a study of Premature Ovarian Failure and Effects of Chemotherapy, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- 196 participants
- Enrollment target
- 1
- Study location
Study Summary
Women of reproductive age who will receive treatment for cancer that includes chemotherapy may participate in a study measuring ovarian function over time. Eligible women are asked to complete a questionnaire, a menstrual diary, a brief physical examination, an ultrasound, and a blood test before, during and after cancer treatment.
Primary Outcome
20 mls blood will be obtained at stated timepoints for determining levels of Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH), Estradiol (E2), Inhibin B, and Anti-mullerian Hormone (AMH). In menstruating girls and young women hormone measures will be obtained during the early follicular phase of the menstrual cycle (days 1-4). In women with irregular cycles the testing will be done spontaneously without regard for the bleeding pattern.
Conditions Studied
Study Locations (1)
Pennsylvania
- University of Pennsylvania, Reproductive Research Unit - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2009-02 |
| Est. Completion | 2028-12 |
What the registry record for NCT02467231 still lists
NCT02467231 is an observational study that tracks outcomes without assigning an intervention. The registered 196 participants enrollment target is mid-sized for trials with a published cap, above the 25-participant average among 3 other Premature Ovarian Failure trials with a reported enrollment target (684% higher).
The record links to 2 conditions, with Premature Ovarian Failure appearing as the primary indexed condition, and to 0 interventions.
NCT02467231 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02467231 about?
NCT02467231 is a clinical study titled "Ovarian Reserve After Cancer: Longitudinal Effects". Women of reproductive age who will receive treatment for cancer that includes chemotherapy may participate in a study measuring ovarian function over time. Eligible women are asked to complete a questionnaire, a menstrual diary, a brief physical examination, an ultrasound, and a blood test before, d...
What is the current status of trial NCT02467231?
This trial is currently active not recruiting. The enrollment target is 196 participants. The study started on 2009-02. Estimated completion is 2028-12.
What conditions does trial NCT02467231 study?
This clinical trial studies the following conditions: Premature Ovarian Failure, Effects of Chemotherapy.
Who is sponsoring clinical trial NCT02467231?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02467231 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premature Ovarian Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02822768 · 196 participants · NA
Packing Versus no Packing for Cutaneous Abscess
- NCT04250259 · 196 participants · Phase 2
SAMe Trial for Patients With Alcoholic Cirrhosis
- NCT05142592 · 196 participants · Phase 1
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
- NCT05317832 · 196 participants · Phase 2
Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia